Abstract
Background: Due to hypothalamic tumour involvement and/or treatment related hypothalamic damage, up to 75% of childhood craniopharyngioma patients (CP) develop hypothalamic obesity.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Experimental and Clinical Endocrinology & Diabetes
Paper Title
Journal
Date
